Clinical pharmacology of the angiotensin converting enzyme inhibitor, enalapril
Détails
ID Serval
serval:BIB_41FF412A119D
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Institution
Titre
Clinical pharmacology of the angiotensin converting enzyme inhibitor, enalapril
Périodique
Acta Cardiologica
ISSN
0001-5385 (Print)
Statut éditorial
Publié
Date de publication
1986
Volume
41
Numéro
5
Pages
341-50
Notes
Journal Article
Review
Review
Résumé
Enalapril is a new angiotensin converting enzyme inhibitor which, when absorbed by the digestive tract, is converted to enalaprilat. This metabolite is, in fact, the active form of enalapril. Its duration of action is sufficiently long so that enalapril can be administered in a single daily dose. Enalapril has been proved to be a highly effective therapeutic agent which is well tolerated by patients with arterial hypertension or severe congestive heart failure.
Mots-clé
*Angiotensin-Converting Enzyme Inhibitors
Enalapril/*pharmacology/therapeutic use
Heart Failure, Congestive/drug therapy
Humans
Hypertension/drug therapy
Pubmed
Web of science
Création de la notice
05/03/2008 16:41
Dernière modification de la notice
20/08/2019 13:43